Wedoany.com Report-Oct. 20, Givaudan, headquartered in Zurich, Switzerland, has officially opened its White Biotechnology Innovation Centre (BIC) in Toulouse, France, marking a key step in expanding its biotechnology capabilities and accelerating the development of high-precision beauty ingredients. The new centre is part of Givaudan’s broader biotechnology R&D and innovation ecosystem and will operate in close synergy with its other European sites in Orsay and Pomacle. In parallel, the company is also expanding in the United States with a new manufacturing hub in Ohio, supporting its global growth strategy.

Givaudan recently celebrated the opening of an advanced biotechnology center in Toulouse

The Toulouse BIC focuses on white biotechnology to enhance Givaudan Active Beauty’s offerings, which involve designing and producing molecules for cosmetics that combine efficacy and consumer appeal. The centre features advanced laboratories, including a dedicated fermentation lab and a biocatalysis development area, allowing the company to efficiently scale up new scientific concepts and transform them into next-generation beauty ingredients.

Gilles Andrier, CEO of Givaudan, said: “Opening the White Biotechnology Innovation Centre in Toulouse is a milestone in Givaudan’s strategy to pioneer sustainable and scientifically supported cosmetic ingredients. This new centre reinforces Givaudan’s global footprint, enhancing collaboration across our different sites to co-create the future of beauty, in line with our 2030 strategy.”

The facility is designed to promote collaboration between marketing and R&D teams, enabling the development of original and innovative ingredient solutions tailored to customer needs. Markus Rassmann, Head of Active Beauty, emphasized: “This Innovation Centre is designed to foster teamwork and creativity between marketing and R&D. It will allow us to service our customers with original and award-winning innovative ingredient solutions.”

By centralizing expertise in fermentation, biocatalysis, and molecular design, the Toulouse BIC enhances Givaudan’s ability to deliver sustainable and scientifically validated cosmetic ingredients. The centre also aligns with the company’s 2030 strategy to expand global operations, strengthen innovation pipelines, and address growing consumer demand for high-performance, environmentally conscious beauty products.

Givaudan’s expansion underscores the company’s commitment to leveraging biotechnology for sustainable innovation. The new centre will enable faster development cycles, facilitate the scale-up of promising research, and support cross-site collaboration, integrating insights from its European and U.S. operations.

Overall, the Toulouse BIC represents a strategic investment in research, innovation, and global collaboration, reinforcing Givaudan’s position as a leading provider of advanced cosmetic ingredients. By combining state-of-the-art facilities with a strong focus on creativity and scientific rigor, the centre will play a key role in driving next-generation beauty solutions while supporting sustainability and efficiency in ingredient development.

This move positions Givaudan to respond to evolving market demands, deliver high-quality, scientifically backed products, and strengthen its global innovation network, highlighting the company’s focus on integrated R&D, customer collaboration, and sustainable growth.